Den Otter W - Search Results

1

Re: Editorial comment on Role of marker lesion when applying intravesical instillations of IL-2 for non-muscle-invasive bladder cancer comparison of the therapeutic effects in two pilot studies: D. P. Wood J Urol 2014; 191: 348.

Den Otter W. Den Otter W. J Urol. 2015 Feb;193(2):734-5. doi: 10.1016/j.juro.2014.07.122. Epub 2014 Nov 11. J Urol. 2015. PMID: 25445581 No abstract available.

2

Role of marker lesion when applying intravesical instillations of IL-2 for non-muscle-invasive bladder cancer comparison of the therapeutic effects in two pilot studies.

Den Otter W, Van Moorselaar RJ, Jacobs JJ, Haar RT, Koten JW, Dobrowolski Z, Lipczynski W, Pašukonienė V, Characiejus D, Jankevičius F, Eidukevičius R, De Reijke TM. Den Otter W, et al. Anticancer Res. 2013 May;33(5):2099-105. Anticancer Res. 2013. PMID: 23645761

3

Intravesical interleukin-2 in T1 papillary bladder carcinoma: regression of marker lesion in 8 of 10 patients.

Den Otter W, Dobrowolski Z, Bugajski A, Papla B, Van Der Meijden AP, Koten JW, Boon TA, Siedlar M, Zembala M. Den Otter W, et al. J Urol. 1998 Apr;159(4):1183-6. doi: 10.1097/00005392-199804000-00021. J Urol. 1998. PMID: 9507828 Clinical Trial.

4

Therapeutic response of untreatable hepatocellular carcinoma after application of the immune modulators IL-2, BCG and melatonin.

Tomov B, Popov D, Tomova R, Vladov N, Den Otter W, Krastev Z. Tomov B, et al. Among authors: den otter w. Anticancer Res. 2013 Oct;33(10):4531-5. Anticancer Res. 2013. PMID: 24123026

5

Effective Treatment of Transmissible Venereal Tumors in Dogs with Vincristine and IL2.

DEN Otter W, Hack M, Jacobs JJ, Tan JF, Rozendaal L, VAN Moorselaar RJ. DEN Otter W, et al. Anticancer Res. 2015 Jun;35(6):3385-91. Anticancer Res. 2015. PMID: 26026099

6

Treatment of transmissible venereal tumors in dogs with intratumoral interleukin-2 (IL-2). A pilot study.

Den Otter W, Hack M, Jacobs JJ, Tan JF, Rozendaal L, Van Moorselaar RJ. Den Otter W, et al. Anticancer Res. 2015 Feb;35(2):713-7. Anticancer Res. 2015. PMID: 25667450

7

Local therapy of cancer with free IL-2.

Den Otter W, Jacobs JJ, Battermann JJ, Hordijk GJ, Krastev Z, Moiseeva EV, Stewart RJ, Ziekman PG, Koten JW. Den Otter W, et al. Cancer Immunol Immunother. 2008 Jul;57(7):931-50. doi: 10.1007/s00262-008-0455-z. Cancer Immunol Immunother. 2008. PMID: 18256831 Free PMC article.

8

Comparison of the efficacy of local treatment of equine sarcoids with IL-2 or cisplatin/IL-2.

Spoormakers TJ, Klein WR, Jacobs JJ, Van Den Ingh TS, Koten JW, Den Otter W. Spoormakers TJ, et al. Among authors: den otter w. Cancer Immunol Immunother. 2003 Mar;52(3):179-84. doi: 10.1007/s00262-002-0369-0. Epub 2003 Feb 4. Cancer Immunol Immunother. 2003. PMID: 12649747 Free PMC article.

9

Local low-dose IL-2 therapy.

Den Otter W, Balemans L, Battermann JJ, Bernsen MR, Cadee JA, Dobrowolski Z, Everse LA, Fiszer-Maliszewska L, Gavhumende R, De Groot JW, De Groot K, Hennink WE, Hill FW, Jurgenliemp-Schulz I, Klein WR, Koten JW, Maas RA, Steerenberg P, Stewart R, Zembala M. Den Otter W, et al. Hepatogastroenterology. 1999 May;46 Suppl 1:1280-6. Hepatogastroenterology. 1999. PMID: 10429975

10

Treatment of stage III-IV nasopharyngeal carcinomas by external beam irradiation and local low doses of IL-2.

Jacobs JJ, Hordijk GJ, Jürgenliemk-Schulz IM, Terhaard CH, Koten JW, Battermann JJ, Den Otter W. Jacobs JJ, et al. Among authors: den otter w. Cancer Immunol Immunother. 2005 Aug;54(8):792-8. doi: 10.1007/s00262-004-0641-6. Epub 2004 Dec 31. Cancer Immunol Immunother. 2005. PMID: 15627211 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

297 results

Search Page